Top Clinical Trials companies in United States by Share Price

This ranking features the top 253 Clinical Trials companies in United States ranked by Share Price, totalling a Share Price of USD 4.55 K, for January 15, 2025.

United States

Clinical Trials

#	Name	Share Price	Reported Date	Stock Price	Change	Country
1	Vertex Pharmaceuticals Incorporated 1 VRTX	USD 411.66	Jan. 14, 2025	USD 411.66	-0.41%	United States
2	Medpace Holdings, Inc. 2 MEDP	USD 330.91	Jan. 14, 2025	USD 330.91	-5.99%	United States
3	Madrigal Pharmaceuticals, Inc. 3 MDGL	USD 274.12	Jan. 14, 2025	USD 274.12	-9.74%	United States
4	Alnylam Pharmaceuticals, Inc. 4 ALNY	USD 240.51	Jan. 14, 2025	USD 240.51	-6.88%	United States
5	Charles River Laboratories International, Inc. 5 CRL	USD 178.08	Jan. 14, 2025	USD 178.08	-6.34%	United States
6	Krystal Biotech, Inc. 6 KRYS	USD 142.64	Jan. 14, 2025	USD 142.64	-5.10%	United States
7	Neurocrine Biosciences, Inc. 7 NBIX	USD 139.51	Jan. 14, 2025	USD 139.51	-2.46%	United States
8	Intra-Cellular Therapies, Inc. 8 ITCI	USD 126.89	Jan. 14, 2025	USD 126.89	-0.24%	United States
9	Sarepta Therapeutics, Inc. 9 SRPT	USD 118.83	Jan. 14, 2025	USD 118.83	0.34%	United States
10	Blueprint Medicines Corporation 10 BPMC	USD 102.56	Jan. 14, 2025	USD 102.56	-0.77%	United States
11	Axsome Therapeutics, Inc. 11 AXSM	USD 84.60	Jan. 14, 2025	USD 84.60	-5.23%	United States
12	Nuvalent, Inc. 12 NUVL	USD 72.39	Jan. 14, 2025	USD 72.39	0.74%	United States
13	Incyte Corporation 13 INCY	USD 71.93	Jan. 14, 2025	USD 71.93	-0.61%	United States
14	Praxis Precision Medicines, Inc. 14 PRAX	USD 65.84	Jan. 14, 2025	USD 65.84	2.84%	United States
15	Arcellx, Inc. 15 ACLX	USD 64.65	Jan. 14, 2025	USD 64.65	-4.02%	United States
16	Disc Medicine, Inc. 16 IRON	USD 57.83	Jan. 14, 2025	USD 57.83	-1.55%	United States
17	Belite Bio, Inc 17 BLTE	USD 54.36	Jan. 14, 2025	USD 54.36	-2.16%	United States
18	Corcept Therapeutics Incorporated 18 CORT	USD 51.66	Jan. 14, 2025	USD 51.66	1.18%	United States
19	Janux Therapeutics, Inc. 19 JANX	USD 45.35	Jan. 14, 2025	USD 45.35	0.64%	United States
20	Cytokinetics, Incorporated 20 CYTK	USD 45.23	Jan. 14, 2025	USD 45.23	-3.17%	United States
21	Mirum Pharmaceuticals, Inc. 21 MIRM	USD 43.32	Jan. 14, 2025	USD 43.32	-1.54%	United States
22	Soleno Therapeutics, Inc. 22 SLNO	USD 42.54	Jan. 14, 2025	USD 42.54	-1.21%	United States
23	Revolution Medicines, Inc. 23 RVMD	USD 39.83	Jan. 14, 2025	USD 39.83	-6.44%	United States
24	Supernus Pharmaceuticals, Inc. 24 SUPN	USD 37.82	Jan. 14, 2025	USD 37.82	0.66%	United States
25	Guardant Health, Inc. 25 GH	USD 37.46	Jan. 14, 2025	USD 37.46	-1.68%	United States
26	Protagonist Therapeutics, Inc. 26 PTGX	USD 36.67	Jan. 14, 2025	USD 36.67	-1.26%	United States
27	Exelixis, Inc. 27 EXEL	USD 35.65	Jan. 14, 2025	USD 35.65	0.99%	United States
28	Crinetics Pharmaceuticals, Inc. 28 CRNX	USD 35.62	Jan. 14, 2025	USD 35.62	-8.62%	United States
29	Biohaven Pharmaceutical Holding Company Ltd. 29 BHVN	USD 35.57	Jan. 14, 2025	USD 35.57	-5.10%	United States
30	Vera Therapeutics, Inc. 30 VERA	USD 34.59	Jan. 14, 2025	USD 34.59	-0.52%	United States
31	Viking Therapeutics, Inc. 31 VKTX	USD 33.93	Jan. 14, 2025	USD 33.93	-12.73%	United States
32	SpringWorks Therapeutics, Inc. 32 SWTX	USD 32.50	Jan. 14, 2025	USD 32.50	-12.19%	United States
33	Legend Biotech Corporation 33 LEGN	USD 31.64	Jan. 14, 2025	USD 31.64	-2.65%	United States
34	Aligos Therapeutics, Inc. 34 ALGS	USD 30.05	Jan. 14, 2025	USD 30.05	-12.49%	United States
35	TG Therapeutics, Inc. 35 TGTX	USD 29.74	Jan. 14, 2025	USD 29.74	7.48%	United States
36	Edgewise Therapeutics, Inc. 36 EWTX	USD 27.52	Jan. 14, 2025	USD 27.52	8.65%	United States
37	Avidity Biosciences, Inc. 37 RNA	USD 27.05	Jan. 14, 2025	USD 27.05	-4.79%	United States
38	Castle Biosciences, Inc. 38 CSTL	USD 25.46	Jan. 14, 2025	USD 25.46	-2.64%	United States
39	Structure Therapeutics Inc. 39 GPCR	USD 25.38	Jan. 14, 2025	USD 25.38	0.87%	United States
40	Monopar Therapeutics Inc. 40 MNPR	USD 24.98	Jan. 14, 2025	USD 24.98	-2.76%	United States
41	ArriVent BioPharma, Inc. Common Stock 41 AVBP	USD 24.85	Jan. 14, 2025	USD 24.85	-2.24%	United States
42	Celldex Therapeutics, Inc. 42 CLDX	USD 22.94	Jan. 14, 2025	USD 22.94	-5.67%	United States
43	Immunovant, Inc. 43 IMVT	USD 22.88	Jan. 14, 2025	USD 22.88	0.57%	United States
44	Akero Therapeutics, Inc. 44 AKRO	USD 21.87	Jan. 14, 2025	USD 21.87	-3.36%	United States
45	Enliven Therapeutics, Inc. 45 ELVN	USD 20.46	Jan. 14, 2025	USD 20.46	-7.29%	United States
46	Instil Bio, Inc. 46 TIL	USD 20.03	Jan. 14, 2025	USD 20.03	5.31%	United States
47	Dianthus Therapeutics, Inc. 47 DNTH	USD 19.88	Jan. 14, 2025	USD 19.88	-13.71%	United States
48	Xencor, Inc. 48 XNCR	USD 19.11	Jan. 14, 2025	USD 19.11	-5.68%	United States
49	Denali Therapeutics Inc. 49 DNLI	USD 18.74	Jan. 14, 2025	USD 18.74	-4.34%	United States
50	Tourmaline Bio, Inc. 50 TRML	USD 18.60	Jan. 14, 2025	USD 18.60	-4.47%	United States

1 2 3 4 5 6

Frequently Asked Questions

Which Clinical Trials company in United States has the highest Share Price ?

The Clinical Trials company in United States with the highest Share Price is Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX) at USD 411.66.
Which Clinical Trials company in United States has the lowest Share Price ?

The Clinical Trials company in United States with the lowest Share Price is Cardio Diagnostics Holdings, Inc. (NasdaqCM: CDIO) at USD 0.57.

What are the top 10 Clinical Trials companies in United States by Share Price ?

The top 10 Clinical Trials companies in United States by Share Price are Vertex Pharmaceuticals Incorporated, Medpace Holdings, Inc., Madrigal Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Charles River Laboratories International, Inc., Krystal Biotech, Inc., Neurocrine Biosciences, Inc., Intra-Cellular Therapies, Inc., Sarepta Therapeutics, Inc. and Blueprint Medicines Corporation.
What are the bottom 10 Clinical Trials companies in United States by Share Price ?

The bottom 10 Clinical Trials companies in United States by Share Price are Cardio Diagnostics Holdings, Inc., Lineage Cell Therapeutics, Inc., Mersana Therapeutics, Inc., CytomX Therapeutics, Inc., Allakos Inc., Calidi Biotherapeutics, Inc., Context Therapeutics Inc., Immunic, Inc., Allarity Therapeutics, Inc. and Prelude Therapeutics Incorporated.